Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Scully Royalty Srl Stock Overpriced Now Price At 7.40 Down 0.13 20260410 Inmb Stock Analysis Inmune Bio Inc. Common Stock Holds 1.21 Level After 1.63 Daily Dip 20260403 Should I Hold Matson Matx Stock Now Price At 168.11 Up 0.60 20260408 Can Mama S Creations Mama Stock Beat The Market Price At 14.89 Down 0.20 20260406 Why Is Brookfield Beph Stock Outperforming Recently Price At 14.76 Up 0.96 20260407 LZ LegalZoomcom Inc shares climb on doubledigit yearoveryear revenue growth despite minor EPS miss INAB IN8bio Inc delivers narrower than expected Q4 2025 loss shares tick higher on positive investor sentiment TUSK Mammoth stock climbs 17 despite huge Q4 earnings miss revenue down 29 YoY What you need to know before buying Bank7 BSVN Market Focus 20260507 Is Presidio FTW stock near a pivot level Earnings Report UMBFO UMB posts 52 percent Q4 2025 EPS upside shares climb 107 percent amid positive investor sentiment EIC Eagle reports quarterly results management highlights portfolio performance and maintains distribution policy amid market volatility ONFO Onfolio Holdings unveils targeted niche content site acquisition plans to boost longterm recurring revenue What Meridian Corporation MRBK management focus reveals about priorities 115 20260511 What MYR Group MYRG management said that matters most Q1 2026 Profit Surprises Why Urban One UONEK might be the portfolio Builder you need Breakdown Watch 20260506 WHFCL WhiteHorse notches narrow Q4 2025 earnings beat shares edge fractionally lower in todays trading KraneShares CSI China Internet ETF KWEB Assessing RiskReward Tradeoffs of Its Linked Covered Call Income Strategy GM General delivers 102 percent Q4 2025 EPS beat shares rise 047 percent in daily trading Whats Next for Affiliated MGRB at 1688 20260513 JPMorganLed Bank Group Tightens Credit Line to KKR Private Credit Fund as Losses Mount UK Economy Defies Expectations with 03 Growth in March Amid Geopolitical Headwinds Trump Discloses Large Purchases of Boeing and Nvidia Shares Ahead of China Trip Vox Royalty VOXR Falls 301 Watching 582 Support 20260515 FG Merger FGMCU Stock Consolidating at 1110 Next Move Ahead 20260514 Grade Inflation Surge PostChatGPT Raises Questions for Education Sector and Workforce Western WAL Stock Down 199 Support Test at 7070 20260517 Veralto VLTO Q1 2026 Earnings 107 EPS Surges Past 103 Estimates Dell Tech DELL Smashes Q1 2026 Views with 389 EPS NetSol NTWK Gained 075 Can It Break 423 20260520 THM Rallies 164 as Gold Exploration Stock Approaches Key Resistance Applied Materials Q3 Outlook Surpasses Estimates on AI and Data Center Strength Enphase Energy Shares Surge Following Positive Analyst Coverage from Goldman Sachs Telecoms CEO Warns Europe Faces Dangerous Dependency on US Satellites and AI Iran Standoff Intensifies Trump Rejects Counteroffer Threatening Energy Markets PepsiCo Reportedly Plans Snack Price Hikes in Late June Bloomberg Indicates IESC Q1 2026 Earnings EPS Surges 35 Above Expectations Stock Rises PKX Q4 2025 Earnings Significant EPS Miss Amid Challenging Steel Market Conditions CTXR Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss ASTC Q1 2024 Earnings Loss Per Share Reported Amid No Revenue Stock Declines GYRE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage Cellectis CLLS Stock Dips 127 as Biotech Volatility Persists Key Support at 332 in Focus MFA Financial Inc MFA Edges Lower as Stock Nears Key Support Level First Busey Preferred Stock BUSEP Holds Steady Near Resistance Modest Uptrend Underway GSK Shares Hold Steady Near 51 as Market Awaits Catalysts TPG MITT Crushes Q1 2026 Estimates EPS 026 Tops Views Surging Gas Prices Disproportionately Burden LowerIncome Households New York Fed Study Reveals Pampa PAM Delivers Q1 2026 Beat EPS 21571 vs 195 Expected IranUS Tensions Escalate as Peace Efforts Stall Risking Global Energy Supply Chains ADMA Biologics ADMA Draws Mixed Analyst Views Amid Biotech Sector Focus